Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.
about
Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model.Schmallenberg virus infection of adult type I interferon receptor knock-out mice.Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.In vivo image analysis of BoHV-4-based vector in mice.BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge.Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancerRapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheepBoHV-4-based vector delivering Ebola virus surface glycoprotein.DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus.Beta interferon controls West Nile virus infection and pathogenesis in mice.Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.Primary replication and invasion of the bovine gammaherpesvirus BoHV-4 in the genital mucosae.Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses
P2860
Q30242080-4692999F-B789-41AF-BA7F-659B6EF2BF1AQ34236757-5356B93E-E9A7-46EF-8F22-883CB41E1052Q34336188-F3B01219-8220-471B-A9DF-74A181DCD542Q34673436-8E7BD401-57BD-4B21-82C8-E55C6C0671FEQ34875697-96B3BEFE-D654-432E-A1B0-9787D6D1D164Q35154094-388F58BA-16F6-4340-ABD5-4CC864BD9FDAQ35667240-0DBC6455-E1BB-49AD-838A-D5D1BFA30ED6Q36821263-C022CC48-DBD4-4180-885C-BE3467871C67Q37123514-279119A6-2285-445B-B708-339D0B71CA7FQ37436625-AA58C3EE-F992-494D-B97B-CA6A2E1C1482Q40864230-9B22C19E-F3B3-4A3F-B71E-BDE4939E29BCQ41969743-C27D34A6-785D-4FA0-9225-A618118C2B21Q42780413-E09B7E7F-58EF-475C-82D3-F6FDC9429E12Q43094365-33046136-8704-41F0-951F-C3D3963BCAFEQ47114380-DDD53978-6D2D-492F-989F-3076A2454485Q56902462-D21756D6-11B7-48ED-A4D7-BE2EEC236766
P2860
Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Immunization of knock-out α/β ...... expressing BTV-8 VP2 antigen.
@en
Immunization of knock-out α/β ...... expressing BTV-8 VP2 antigen.
@nl
type
label
Immunization of knock-out α/β ...... expressing BTV-8 VP2 antigen.
@en
Immunization of knock-out α/β ...... expressing BTV-8 VP2 antigen.
@nl
prefLabel
Immunization of knock-out α/β ...... expressing BTV-8 VP2 antigen.
@en
Immunization of knock-out α/β ...... expressing BTV-8 VP2 antigen.
@nl
P50
P1433
P1476
Immunization of knock-out α/β ...... r expressing BTV-8 VP2 antigen
@en
P2093
Carla Mucignat-Caretta
Eva Calvo-Pinilla
P304
P356
10.1016/J.VACCINE.2011.01.075
P407
P577
2011-02-12T00:00:00Z